# Thymulin

> Thymulin is a zinc-dependent nonapeptide hormone produced by thymic epithelial cells, first characterized for its role in T-lymphocyte differentiation and maturation. Its biological activity is strictly zinc-dependent, meaning adequate zinc status is required for the peptide to bind its receptor and exert effects. Research has explored thymulin's role in immune senescence, as circulating levels decline with age, alongside its potential to modulate inflammatory and autoimmune processes. Most available evidence comes from animal and in vitro studies, with more limited human clinical data.

- URL: https://www.lifeconverted.com/peptides/thymulin
- Primary category: Anti-Inflammatory
- Effectiveness rank: #8 in Anti-Inflammatory
- Evidence level: Moderate evidence
- Route: Subcutaneous
- Dose range: 100-400 mcg
- Dose tiers: low 100 mcg; moderate 200 mcg; high 400 mcg
- Half-life: Short, estimated at under 1 hour
- Timing: Morning
- Cycle: 4-8 weeks on, 4 weeks off (Adequate dietary or supplemental zinc status is often discussed as a prerequisite for expected activity)
- Storage: Store lyophilized peptide frozen; reconstituted solution refrigerated and used within 2-3 weeks

## Mechanism of action

Thymulin requires zinc binding to achieve its active conformation, after which it engages receptors on T-lymphocytes to promote differentiation and functional maturation, particularly within the thymus. It has also been studied for effects on cytokine regulation and modulation of autoimmune and inflammatory activity in animal models, including reported effects on sleep and neuroendocrine signaling. Its dependence on zinc status links thymulin research to broader questions about micronutrient status and immune aging.

## Reported benefits

- Studied for support of T-lymphocyte differentiation and thymic function
- Explored in research on age-related immune decline (immunosenescence)
- Investigated for modulation of autoimmune and inflammatory markers in animal models
- May support sleep-related neuroendocrine signaling in preclinical research

## Reported side effects

- Injection site irritation
- Limited human safety and dosing data
- Effects may be blunted by zinc deficiency, complicating interpretation of use
- Theoretical immune modulation risks in autoimmune populations

## Common protocols

- Daily subcutaneous dosing in short cycles alongside adequate zinc intake

## Stacking notes

Sometimes discussed alongside Thymosin Alpha-1 for combined thymic-support research protocols; zinc status is often addressed concurrently

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer